- Home
- AMRN vs XBIT Comparison
AMRN vs XBIT Comparison
Compare AMRN & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMRN
- XBIT
- Stock Information
- Founded
- AMRN 1989
- XBIT 2005
- Country
- AMRN Ireland
- XBIT United States
- Employees
- AMRN N/A
- XBIT N/A
- Industry
- AMRN Biotechnology: Pharmaceutical Preparations
- XBIT Pharmaceuticals and Biotechnology
- Sector
- AMRN Health Care
- XBIT Health Care
- Exchange
- AMRN Nasdaq
- XBIT Nasdaq
- Market Cap
- AMRN 189.2M
- XBIT 194.5M
- IPO Year
- AMRN 1993
- XBIT 2015
- Fundamental
- Price
- AMRN $0.59
- XBIT $3.40
- Analyst Decision
- AMRN Buy
- XBIT
- Analyst Count
- AMRN 1
- XBIT 0
- Target Price
- AMRN N/A
- XBIT N/A
- AVG Volume (30 Days)
- AMRN 1.1M
- XBIT 52.0K
- Earning Date
- AMRN 02-27-2025
- XBIT 03-14-2025
- Dividend Yield
- AMRN N/A
- XBIT N/A
- EPS Growth
- AMRN N/A
- XBIT N/A
- EPS
- AMRN N/A
- XBIT N/A
- Revenue
- AMRN $241,021,000.00
- XBIT N/A
- Revenue This Year
- AMRN N/A
- XBIT N/A
- Revenue Next Year
- AMRN N/A
- XBIT N/A
- P/E Ratio
- AMRN N/A
- XBIT N/A
- Revenue Growth
- AMRN N/A
- XBIT N/A
- 52 Week Low
- AMRN $0.43
- XBIT $3.25
- 52 Week High
- AMRN $1.36
- XBIT $9.96
- Technical
- Relative Strength Index (RSI)
- AMRN 50.48
- XBIT 26.88
- Support Level
- AMRN $0.55
- XBIT $3.40
- Resistance Level
- AMRN $0.61
- XBIT $3.69
- Average True Range (ATR)
- AMRN 0.04
- XBIT 0.20
- MACD
- AMRN -0.00
- XBIT 0.05
- Stochastic Oscillator
- AMRN 26.56
- XBIT 3.85
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.